News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
135 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4152)
February (4569)
March (4908)
April (4902)
May (5255)
June (4735)
July (4593)
August (4725)
September (5112)
October (5032)
November (5368)
December (4315)
Day
1 (311)
2 (226)
3 (215)
4 (135)
5 (41)
6 (37)
7 (334)
8 (261)
9 (251)
10 (270)
11 (148)
12 (7)
13 (14)
14 (211)
15 (296)
16 (213)
17 (255)
18 (136)
19 (2)
20 (6)
21 (259)
22 (190)
23 (133)
24 (25)
25 (1)
26 (1)
27 (5)
28 (86)
29 (107)
30 (84)
31 (55)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
As Death Toll Climbs, WHO Finds No Benefit with 4 Top COVID-19 Treatments
The four promising treatments showed no effect on reducing mortality in ongoing Solidarity Trial.
December 4, 2020
·
2 min read
·
Kate Goodwin
Drug Development
Solid Safety Profile in Hand, Sutro Will Expand Reach of Ovarian Cancer Drug STRO-002
As the dose of Sutro Biopharma’s ovarian cancer drug, STRO-002, increased in an ongoing Phase I dose-escalation trial, survival rates have also increased.
December 4, 2020
·
3 min read
·
Heather McKenzie
RNA Analysis/Transcriptomics Market | North America may gain a dominating position across the market
The RNA analysis/transcriptomics market may gain immense growth across the assessment period of 2019-2029 on the back of the escalating advancements across the transcriptomics sector.
December 4, 2020
·
4 min read
Patient Monitoring Accessories Market | High Prevalence of Chronic Diseases to Support Demand for these Accessories in the Market
Patient monitoring accessories refer to those devices that are utilized independently or it works with patient monitoring medical devices so as to offer timely and efficacious treatment.
December 4, 2020
·
3 min read
Therapeutic Nuclear Medicines Market: Increase in the Occurrence of Prostate Cancer is Expected to Drive the Market
Therapeutic nuclear medicines are drug detailing that comprises of radioactive substances.
December 4, 2020
·
5 min read
Outbound Medical Tourism Services Market: Increasing per Capita Income and Capability of Expenditure Is Likely to Boost the Market
The mobility across the international boundaries for medical conduct is generally known as Medical tourism.
December 4, 2020
·
5 min read
Knee Reconstruction Devices Market: Increasing Knee Accidents are Estimated to Fuel Growth of the Market
Knee reconstruction comprises the relocation and repositioning of the ligaments, which is stabilizing ligament holding the tibia.
December 4, 2020
·
5 min read
Clean Room Panels Market: Competitive Analysis & Regional Assessment
Growing use of clean room facilities in numerous end-use industries is likely to boost demand opportunities in the global clean room panels market between 2020 and 2030.
December 4, 2020
·
4 min read
Drug Development
Clover Biopharmaceuticals Announces Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates
Clover’s protein-based COVID-19 vaccine candidates adjuvanted with either GSK’s pandemic adjuvant system or Dynavax’s CpG 1018 plus alum induced strong neutralizing immune responses in 150 adult and elderly subjects from the Phase 1 clinical study.
December 4, 2020
·
8 min read
Business
HEXO Corp to Release Fiscal First Quarter 2021 Financial Results and Host Investor WebcastAnnual General Meeting Scheduled for December 11, 2020
HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) plans to release its financial results for the fiscal first quarter 2021, before market hours on December 14, 2020, as well as host a webcast for investors beginning at 8:30 a.m. EST
December 4, 2020
·
1 min read
Previous
2 of 14
Next